Tapping into WHO expertise allows Uzbekistan to increase COVID-19 testing

▴ tapping-who-expertise-uzbekistan-increase-covid19-testing
WHO/Europe and UNFPA collected data which established that there were systems for rapid detection of different viruses spread out across the country

Toward the beginning of the COVID-19 scourge in Uzbekistan, sourcing and putting in new hardware to complete testing in research facilities end up being troublesome. To help reinforce readiness, WHO/Europe, the United Nations Population Fund (UNFPA), the International Agency for Research on Cancer (IARC) and the French Embassy in Uzbekistan discovered imaginative manners to repurpose machines as of now set up in the nation's emergency clinics.

WHO/Europe and UNFPA gathered information which set up that there were at that point 60 polymerase chain response frameworks for fast discovery of various infections spread out the nation over which might be utilized to test for COVID-19. A gathering of organizations and authorities, united by WHO/Europe, was at that point working together on a pilot study to start screening for cervical malignancy in the nation. They guided wellbeing specialists to repurpose the machines as opposed to attempting to source new ones.

"The way that we previously had this system instead of individuals who knew and believed each other made it conceivable to discover arrangements," says Marilys Corbex, Senior Technical Officer on non-communicable maladies, WHO/Europe. "The data and mastery we gave helped experts in Uzbekistan to more readily comprehend their alternatives."

Everyone that was required was for a cartridge to be embedded into an effectively accessible machine to test for COVID-19. This could spare assets at a crucial time while helping Uzbekistan to find a way to manage the COVID-19 emergency.

"Experts in Uzbekistan were attempting to locate the best test at the national level. We gave them that there were machines previously being utilized for HIV and tuberculosis testing, and intended to be utilized for cervical malignant growth screening, which could promptly test for COVID-19, setting aside the time and cash," clarifies Dr. Isabelle Heard, a specialist from IARC, who gave specialized direction.

Dr. Heard focuses on the quality of the interdisciplinary and interagency organize as of now set up at that point, which made it conceivable to adjust rapidly and effectively to the developing

COVID-19 circumstance.

In spite of the fact that the repurposed machines were not utilized for Covid-19 testing at long last, the activity helped the experts in Uzbekistan better evaluate their alternatives and maintain a strategic distance from possibly costly slip-ups.

Tags : #Uzbekistan #COVID-19 #Testing #WHO

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024